Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Mohammed A, Mamoojee YH, Quinton R

Publication type: Review

Publication status: Published

Journal: Best Practice and Research: Clinical Endocrinology and Metabolism

Year: 2024

Pages: epub ahead of print

Online publication date: 25/08/2024

Acceptance date: 02/04/2024

ISSN (print): 1521-690X

ISSN (electronic): 1532-1908

Publisher: Elsevier B.V.

URL: https://doi.org/10.1016/j.beem.2024.101930

DOI: 10.1016/j.beem.2024.101930

ePrints